Androgens in childhood acquired aplastic anaemia in Chandigarh, India

Tropical Doctor

Volumn 34, Issue 3, 2004, Pages 149-152

  Marwaha, R K ^a   Bansal, Deepak ^a   Trehan, Amita ^a   Varma, Neelam ^b  

^a Department of Pediatrics   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; STANOZOLOL;

ADOLESCENT; APLASTIC ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INDIA; LYMPHOID CELL; MALE; MEDICAL RECORD; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ANDROGENS; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INDIA; INFANT; MALE; MEDICAL RECORDS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STANOZOLOL; TREATMENT OUTCOME;

EID: 3042789488     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1177/004947550403400307     Document Type: Article

References (21)

1. Alter BP, Young NS. The bone marrow failure syndromes. In: Nathan DG, Orkin SH, eds. Nathan and Oski's Hematology of Infancy and Childhood, 5th edn. Philadelphia: WB Saunders, 1998: 237-335.
2. Camitta BM, Rappeport JM, Parkman R, Nathan DG. Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood, 1975; 45: 355-63.
3. Bacigalupo A, Hows J, Gluckman E et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA Working Party. Br J Haematol, 1988; 70: 177-82.
4. Frickhofen N, Rosenfeld SJ. Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclos-porine. Semin Hematol, 2000; 37: 56-68.
5. Alexanian R. Erythropoietin and erythropoiesis in anemic man following androgens. Blood, 1969; 33: 564-72.
6. Shahidi NT, Diamond LK. Testosterone-induced remission in aplastic anemia of both acquired and congenital types. New Engl J Med, 1961; 264: 953-67.
7. Camitta BM, Storb R, Thomas ED. Aplastic anemia [First of two parts]. Pathogenesis, diagnosis, treatment and prognosis. New Engl J Med, 1982; 306: 645-52.
8. Camitta BM, Storb R, Thomas ED. Aplastic anemia [Second of two parts]. Pathogenesis, diagnosis, treatment and prognosis. New Eng J Med, 1982; 306: 712-18.
9. Khatib Z, Wilimas J, Wang W. Outcome of moderate aplastic anemia in children. Am J Pediatr Hematol Oncol, 1994;16: 80-5.
10. Heyn RM, Ertel IJ, Tubergen DG. Course of acquired aplastic anemia in children treated with supportive care. JAMA, 1969; 208: 1372-8.
11. Daiber A, Herve L, Con I, Donoso A. Treatment of aplastic anemia with nandrolone decanoate. Blood, 1970;36: 748-53.
12. Skaberg KO, Engstedt L, Jameson S et al. Oxymethalone treatment in hypoproliferative anemia: frequency of response. Acta Haemat, 1973; 49: 321-30.
13. Hengstum MV, Steenbergen J, Haanen C. Clinical course in 28 unselected patients with aplastic anaemia treated with anabolic steroids. Br J Haematol, 1979; 41: 323-33.
14. Kamamoto T, Ohkubo T, Yamagishi M, Yda Y, Uchino N. Correlation between in vitro and in vivo response to androgens in patients with aplastic anemia. Int J Cell Cloning, 1984; 2: 173-84.
15. Najean Y, Pecking A. Prognostic factors in acquired aplastic anemia. A study of 352 cases. Am J Med, 1979;67: 564-71.
16. Gluckman E, Devergie A, Poros A, Degoulet P. Results of immunosuppression in 170 cases of severe aplastic anaemia. Report of the European Group of Bone Marrow Transplant (EGBMT). Br J Haematol, 1982; 51: 541-50.
17. Najean Y, Pecking A, LeDanvic M. Androgen therapy of aplastic anemia - a prospective study of 352 cases. Scand J Haematol, 1979; 22: 343-56.
18. Li FP, Alter BP, Nathan DG. The mortality of acquired aplastic anemia in children. Blood, 1972; 40: 153-62.
19. Freedman MH, Saunders EF. Residual abnormality in acquired aplastic anemia of childhood. JAMA, 1974;228: 201-2.
20. Brodsky RA, Sensenbrenner LL, Jones RJ. Complete remission in severe aplastic anemia after high dose cyclophosphamide without bone marrow transplantation. Blood, 1996; 87: 491-4.
21. Tisdale JF, Dunn DE, Geller N et al. High-dose cyclophosphamide in severe aplastic anaemia: a randomised al. Lancet, 2000; 356: 1554-9.